ERBB2 and neoplasm: The infusion of CAR-147-Mac significantly inhibited HER2+ 4T1 tumor growth in mice along with an up-regulation of the anti-tumor cytokines such as IL-12 and IFN-gamma, thus suggesting that this strategy involves both local modulation and systemic anti-tumor responses.